Heat Biologics Inc (HTBX)

1.25
0.01 0.81
NASDAQ : Health Care
Prev Close 1.24
Open 1.43
Day Low/High 1.20 / 1.44
52 Wk Low/High 0.40 / 7.00
Volume 4.50M
Avg Volume 1.79M
Exchange NASDAQ
Shares Outstanding 23.88M
Market Cap 24.60M
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Heat Biologics, Inc. - HTBX

INVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Heat Biologics, Inc. - HTBX

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Heat Biologics, Inc.

Heat Biologics Provides Corporate Update And Reports Third Quarter 2016 Financial Results

Heat Biologics Provides Corporate Update And Reports Third Quarter 2016 Financial Results

Remains on Track to Report Multiple Topline Data Readouts this Quarter

Heat Biologics Selects Adaptive Biotechnologies To Discover Potential Clinical Biomarkers To Advance Novel Immunotherapies

Heat Biologics Selects Adaptive Biotechnologies To Discover Potential Clinical Biomarkers To Advance Novel Immunotherapies

Adaptive's immunoSEQ Assay demonstrated a trend between established anti-tumor immune responses and clinical outcomes with HS-410

7 Stocks Under $10 to Trade for Big Profits

7 Stocks Under $10 to Trade for Big Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

8 Breakout Stocks Under $10 to Trade for Big Profits

8 Breakout Stocks Under $10 to Trade for Big Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Heat Biologics And OncoSec Present Data At The American Conference For Cancer Research (AACR) Annual Meeting

Heat Biologics And OncoSec Present Data At The American Conference For Cancer Research (AACR) Annual Meeting

Preclinical findings demonstrate that intratumoral electroporation activate tumor neoantigen-specific immune responses

OncoSec And Heat Biologics Present Data At The American Conference For Cancer Research (AACR) Annual Meeting

OncoSec And Heat Biologics Present Data At The American Conference For Cancer Research (AACR) Annual Meeting

Preclinical findings demonstrate that intratumoral electroporation activates tumor neoantigen-specific immune responses

Heat Biologics Announces Cost-Saving Measures And Focused Corporate Strategy To Achieve Important Clinical Milestones

Heat Biologics Announces Cost-Saving Measures And Focused Corporate Strategy To Achieve Important Clinical Milestones

Cost-saving measures enable Heat to achieve Phase 2 HS-410 bladder cancer data readout in 4Q:16 with its current cash on-hand